Gennex Laboratories informs about disclosure

16 Sep 2022 Evaluate
Gennex Laboratories has informed that the exchange has received the disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on September 16, 2022 for Premier Fiscal Services.

The above information is a part of company’s filings submitted to BSE.

Gennex Lab Share Price

15.52 1.12 (7.78%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.